Representatives Option Clause Samples

The Representative’s Option clause grants a designated representative the authority to make certain decisions or take specific actions on behalf of a party within the agreement. Typically, this clause outlines the scope of the representative’s powers, such as the ability to exercise purchase options, approve amendments, or execute documents. By clearly defining the representative’s rights and limitations, the clause ensures efficient decision-making and avoids delays that could arise from requiring direct approval from all parties involved.
Representatives Option. On the First Closing Date, the Company will issue to you, for a consideration of $290.00 and upon the terms and conditions set forth in the form of Representative's Option annexed as an exhibit to the Registration Statement, the Representative's Option to purchase 290,000 Units. In the event of conflict in the terms of this Agreement and the Representative's Option, the language of the Representative's Option shall control.
View Source
Representatives Option. Each Underwriter shall be entitled to purchase such portion of the Representative's Option, referred to in Section 12 of the Underwriting Agreement, as the Representative, in its discretion, determines.
View Source
Representatives Option. (i) The Company hereby agrees to issue and sell to the Representatives (and/or its designees) on the Closing Date an option (“Representative’s Option”) for the purchase of an aggregate of 175,000 shares of Common Stock (5% of the Shares) for an aggregate purchase price of $100.00. The Representative’s Option shall be exercisable, in whole or in part, commencing on a date which is one year from the effective date of the Registration Statement and expiring on the five-year anniversary of the effective date of the Registration Statement at an initial exercise price per Share of $____, which is equal to 120% of the initial public offering price of the Shares. The Representative’s Option and the shares of Common Stock issuable upon exercise thereof are sometimes hereinafter referred to collectively as the “Representative’s Securities.” The Representative understands and agrees that there are significant restrictions pursuant to FINRA Rule 5110 against transferring the Representative’s Option and the underlying shares of Common Stock during the first year after the effective date and by its acceptance thereof shall agree that it will not, sell, transfer, assign, pledge or hypothecate the Representative’s Option, or any potion thereof, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of such securities for a period of one hundred eighty (180) days following the effective date of the Registration Statement to anyone other than (i) an Underwriter or a selected dealer in connection with the offering, or (ii) a bona fide officer or partner of the Representative or of any such Underwriter or selected dealer; and only if any such transferee agrees to the foregoing lock-up restrictions.
View Source
Representatives Option 
View SourceView Similar (9)

Related to Representatives Option

  • Representatives Purchase Option The Company hereby agrees to issue and sell to the Representative (and/or its designees) on the Closing Date, for an aggregate purchase price of $100.00, an option (“Representative’s Purchase Option”) to purchase up to an aggregate of 420,000 Units (the “Representative’s Units”). The Representative’s Purchase Option shall be exercisable whether for cash or on a cashless basis, in whole or in part, commencing on the later of the consummation of a Business Combination or one year from the Effective Date and expiring on the five-year anniversary of the Effective Date at an initial exercise price per Representative’s Unit of $10.00, which is equal to the Offering price per Unit. On the Closing Date, the Company shall deliver to the Representative, upon payment therefor, certificates for the Representative’s Purchase Option in the name or names and in such denominations as the Representative may request. The Representative’s Purchase Option, the Representative’s Units, Common Stock included in the Representative’s Units, Warrants included in the Representative’s Units (the “Representative’s Warrants”) and the Common Stock issuable upon exercise of the Representative’s Warrants are hereinafter referred to collectively as the “Representative’s Securities.” The Public Securities and the Representative’s Securities are hereinafter referred to collectively as the “Securities.”

  • Representative’s Warrant On the Closing date, the Company shall have delivered to the Representative an executed copy of the Representative’s Warrant.

  • Representatives for PFA (a) The HSP’s Representative for purposes of this PFA shall be [insert name, telephone number, fax number and e-mail address.] The HSP agrees that the HSP’s Representative has authority to legally bind the HSP. (b) The LHIN’s Representative for purposes of this PFA shall be: [insert name, telephone number, fax number and e-mail address.]

  • Representatives Warrants The Company hereby agrees to issue to the Representative (and/or its designees) (i) at the Closing Time a warrant (“Closing Time Representative’s Warrants”) for the purchase of an aggregate of [ ● ] shares of Common Stock and (ii) on each Date of Delivery, if any, a warrant (together with the Closing Time Representative’s Warrants, the “Representative’s Warrants”) for the purchase of an aggregate of 3.0% of the number of shares of Common Stock issued on such Date of Delivery. The agreement(s) representing the Representative’s Warrants, in the form attached hereto as Exhibit C (the “Representative’s Warrant Agreement”), shall be exercisable, in whole or in part, commencing on a date which is six (6) months after the Applicable Time and expiring on the five-year anniversary of the Applicable Time at an initial exercise price per share of Common Stock of $[ ● ], which is equal to 125% of the initial public offering price of the Initial Securities. The Representative’s Warrant Agreement and the shares of Common Stock issuable upon exercise thereof are hereinafter referred to together as the “Representative’s Securities.” The Representative understands and agrees that there are significant restrictions pursuant to FINRA Rule 5110 against transferring the Representative’s Warrant Agreement and the underlying shares of Common Stock during the one hundred and eighty (180) days after the Applicable Time and by its acceptance thereof shall agree that it will not sell, transfer, assign, pledge or hypothecate the Representative’s Warrant Agreement, or any portion thereof, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of such securities for a period of one hundred and eighty (180) days following the Applicable Time to anyone other than (i) an Underwriter or a selected dealer in connection with the offering, or (ii) a bona fide officer or partner of the Representative or of any such Underwriter or selected dealer; and only if any such transferee agrees to the foregoing lock-up restrictions. Delivery of the Representative’s Warrant Agreement shall be made at the Closing Time, and shall be issued in the name or names and in such authorized denominations as the Representative may request.

  • Representatives of the Parties 11.1 The Seller has appointed the following authorised representatives for communication with the Buyer in relation to the subject of performance hereunder: In technical matters: 11.2 The Buyer has appointed the following authorised representatives for communication with the Seller in relation to the subject of performance hereunder: In technical matters: